APA (7th ed.) Citation

Katrii, T., Freywald, T., Estrada, M. G., El Zawily, A., Toosi, B., Vizeacoumar, F. S., . . . Leary, S. C. (2025). The DRP1 receptor FIS1 is critical to the expansion of triple-negative breast cancer tumor-initiating cells. Cancer Cell International, 25(1), 1. https://doi.org/10.1186/s12935-025-03909-5

Chicago Style (17th ed.) Citation

Katrii, Tetiana, Tanya Freywald, Malkon G. Estrada, Amr El Zawily, Behzad Toosi, Frederick S. Vizeacoumar, Franco J. Vizeacoumar, Andrew Freywald, and Scot C. Leary. "The DRP1 Receptor FIS1 Is Critical to the Expansion of Triple-negative Breast Cancer Tumor-initiating Cells." Cancer Cell International 25, no. 1 (2025): 1. https://doi.org/10.1186/s12935-025-03909-5.

MLA (9th ed.) Citation

Katrii, Tetiana, et al. "The DRP1 Receptor FIS1 Is Critical to the Expansion of Triple-negative Breast Cancer Tumor-initiating Cells." Cancer Cell International, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12935-025-03909-5.